Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAIRAMAN NAGARAJAN

NPI
1528453941
CMS profile
8789750
Location
BROOKLYN, NY

General Payments · PY2018–2024

$2,393.77

  • Reported across 50 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,420.55

40 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,354.42 39
Education $66.13 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $87.03 1
PY2019 $700.00 1
PY2023 $186.19 8
PY2024 $1,420.55 40

Payment records · PY2024 (40)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $23.68 01/10/2024 Food and Beverage Undisputed 01/23/2026 1115956612 CMS
Amgen Inc. $24.47 02/08/2024 Food and Beverage Undisputed 01/23/2026 1115956616 CMS
AstraZeneca Pharmaceuticals LP $104.00 01/22/2024 Food and Beverage Undisputed 01/23/2026 1110507938 CMS
AstraZeneca Pharmaceuticals LP $22.24 03/29/2024 Food and Beverage Undisputed 01/23/2026 1110511114 CMS
AstraZeneca Pharmaceuticals LP $25.57 05/09/2024 Food and Beverage Undisputed 01/23/2026 1110512602 CMS
AstraZeneca Pharmaceuticals LP $22.82 09/05/2024 Food and Beverage Undisputed 01/23/2026 1110507352 CMS
AstraZeneca Pharmaceuticals LP $22.93 10/04/2024 Food and Beverage Undisputed 01/23/2026 1110515248 CMS
BioCryst US Sales Co., LLC $23.54 04/20/2024 Food and Beverage Undisputed 01/23/2026 1117470798 CMS
BioCryst US Sales Co., LLC $33.16 08/16/2024 Food and Beverage Undisputed 01/23/2026 1117478128 CMS
BioCryst US Sales Co., LLC $19.25 08/23/2024 Food and Beverage Undisputed 01/23/2026 1117470800 CMS
Genentech USA, Inc. $25.02 09/27/2024 Food and Beverage Undisputed 01/23/2026 1133104629 CMS
GENZYME CORPORATION $39.35 01/25/2024 Food and Beverage Undisputed 01/23/2026 1139968017 CMS
GENZYME CORPORATION $26.00 02/16/2024 Food and Beverage Undisputed 01/23/2026 1139968013 CMS
GENZYME CORPORATION $49.39 02/24/2024 Food and Beverage Undisputed 01/23/2026 1139968015 CMS
GENZYME CORPORATION $83.77 03/07/2024 Food and Beverage Undisputed 01/23/2026 1139968053 CMS
GENZYME CORPORATION $26.00 04/18/2024 Food and Beverage Undisputed 01/23/2026 1139968027 CMS
GENZYME CORPORATION $24.38 08/12/2024 Food and Beverage Undisputed 01/23/2026 1139968093 CMS
GlaxoSmithKline, LLC. $21.95 01/27/2024 Food and Beverage Undisputed 01/23/2026 1116593076 CMS
GlaxoSmithKline, LLC. $20.90 03/16/2024 Food and Beverage Undisputed 01/23/2026 1116322307 CMS
GlaxoSmithKline, LLC. $19.16 04/26/2024 Food and Beverage Undisputed 01/23/2026 1116315646 CMS
GlaxoSmithKline, LLC. $32.72 04/27/2024 Food and Beverage Undisputed 01/23/2026 1116456039 CMS
GlaxoSmithKline, LLC. $20.75 06/18/2024 Food and Beverage Undisputed 01/23/2026 1116678583 CMS
GlaxoSmithKline, LLC. $26.52 08/16/2024 Food and Beverage Undisputed 01/23/2026 1116315694 CMS
GlaxoSmithKline, LLC. $20.84 09/14/2024 Food and Beverage Undisputed 01/23/2026 1116208747 CMS
GlaxoSmithKline, LLC. $19.33 10/12/2024 Food and Beverage Undisputed 01/23/2026 1116228175 CMS
Grifols USA, LLC $31.57 03/23/2024 Food and Beverage Undisputed 01/23/2026 1124732581 CMS
kaleo, Inc. $25.49 01/19/2024 Food and Beverage Undisputed 01/23/2026 1126629848 CMS
kaleo, Inc. $29.61 03/01/2024 Food and Beverage Undisputed 01/23/2026 1126629850 CMS
kaleo, Inc. $27.78 06/07/2024 Food and Beverage Undisputed 01/23/2026 1126629852 CMS
kaleo, Inc. $30.47 07/19/2024 Food and Beverage Undisputed 01/23/2026 1126629854 CMS
kaleo, Inc. $25.97 09/18/2024 Food and Beverage Undisputed 01/23/2026 1126629856 CMS
Novartis Pharmaceuticals Corporation $29.82 03/29/2024 Food and Beverage Undisputed 01/23/2026 1087135378 CMS
PFIZER INC. $22.70 08/14/2024 Food and Beverage Undisputed 01/23/2026 1131885293 CMS
Regeneron Healthcare Solutions, Inc. $101.58 02/24/2024 Food and Beverage Undisputed 01/23/2026 1114121475 CMS
Regeneron Healthcare Solutions, Inc. $24.71 05/03/2024 Food and Beverage Undisputed 01/23/2026 1114121477 CMS
Regeneron Healthcare Solutions, Inc. $66.13 07/18/2024 Education Undisputed 01/23/2026 1114121479 CMS
Regeneron Healthcare Solutions, Inc. $26.78 07/19/2024 Food and Beverage Undisputed 01/23/2026 1114121481 CMS
SANOFI-AVENTIS U.S. LLC $148.14 01/05/2024 Food and Beverage Undisputed 01/23/2026 1139968055 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.85 08/19/2024 Food and Beverage Undisputed 01/23/2026 1137640618 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.21 08/21/2024 Food and Beverage Undisputed 01/23/2026 1137640620 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.